NASDAQ: UNCY
Unicycive Therapeutics Inc Stock Ownership - Who owns Unicycive Therapeutics?

Insider buying vs selling

Have Unicycive Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when UNCY insiders and whales buy or sell their stock.

UNCY Shareholders

What type of owners hold Unicycive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shalabh K. Gupta9.47%2,527,449$13.65MInsider
Gaurav Aggarwal6.70%1,789,915$9.67MInsider
Douglas Jermasek0.66%175,012$945.06kInsider
Pramod Gupta0.16%41,845$225.96kInsider
Brigitte Schiller0.16%41,738$225.39kInsider
Wealth Enhancement Advisory Services LLC0.07%19,948$107.72kInstitution
Blkrok0.01%1,413$7.63kInstitution
Vangrd0.00%1,071$5.78kInstitution
Geodec0.00%564$3.05kInstitution
Marwac0.00%548$2.96kInstitution

1 of 3

UNCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UNCY0.02%16.43%
MENS0.00%33.35%
SPRB0.00%100.00%Net SellingNet Buying
CRBU0.04%8.68%Net Selling
HURA0.01%33.07%

Unicycive Therapeutics Stock Ownership FAQ

Who owns Unicycive Therapeutics?

Unicycive Therapeutics (NASDAQ: UNCY) is owned by 0.02% institutional shareholders, 16.43% Unicycive Therapeutics insiders, and 83.55% retail investors. Shalabh K. Gupta is the largest individual Unicycive Therapeutics shareholder, owning 2.53M shares representing 9.07% of the company. Shalabh K. Gupta's Unicycive Therapeutics shares are currently valued at $13.93M.

If you're new to stock investing, here's how to buy Unicycive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.